Global Non opioid Pain Patch Market Research Report 2023(Status and Outlook)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,800	139 Pages	Bosson Research	May, 2023	BOSS18171098

Best Price Guarantee
Price	from $2,800
Length	139 Pages
Publisher	Bosson Research
Published Date	May, 2023
SKU	BOSS18171098

Global Non opioid Pain Patch Market Research Report 2023(Status and Outlook)

Report Overview

A non-opioid pain patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

The Global Non opioid Pain Patch Market Size was estimated at USD 631.4 million in 2022 and is projected to reach USD 755.68 million by 2029, exhibiting a CAGR of 2.60% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Non opioid Pain Patch market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non opioid Pain Patch Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non opioid Pain Patch market in any manner.

Global Non opioid Pain Patch Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Hisamitsu

Mylan

Johnson & Johnson

Actavis

Lingrui

Teikoku Seiyaku

Sanofi

Novartis

Qizheng

Endo

Huarun 999

GSK

Haw Par

Nichiban

Mentholatum

Laboratoires Genevrier

BLUE-EMU

Market Segmentation (by Type)

Lidocaine Patches

Diclofenac Patches

Indomethacin Patches

Counter-Irritant Patches

Fentanyl Patches

Others

Market Segmentation (by Application)

Body Armor & Helmet

Aerospace Materials

Sports Materials

High Strength Rope

Tire

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Non opioid Pain Patch Market

Overview of the regional outlook of the Non opioid Pain Patch Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

1 Research Methodology and Statistical Scope: 1.1 Market Definition and Statistical Scope of Non opioid Pain Patch; 1.2 Key Market Segments; 1.2.1 Non opioid Pain Patch Segment by Type; 1.2.2 Non opioid Pain Patch Segment by Application; 1.3 Methodology & Sources of Information; 1.3.1 Research Methodology; 1.3.2 Research Process; 1.3.3 Market Breakdown and Data Triangulation; 1.3.4 Base Year; 1.3.5 Report Assumptions & Caveats
2 Non opioid Pain Patch Market Overview: 2.1 Global Market Overview; 2.1.1 Global Non opioid Pain Patch Market Size (M USD) Estimates and Forecasts (2018-2029); 2.1.2 Global Non opioid Pain Patch Sales Estimates and Forecasts (2018-2029); 2.2 Market Segment Executive Summary; 2.3 Global Market Size by Region
3 Non opioid Pain Patch Market Competitive Landscape: 3.1 Global Non opioid Pain Patch Sales by Manufacturers (2018-2023); 3.2 Global Non opioid Pain Patch Revenue Market Share by Manufacturers (2018-2023); 3.3 Non opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3); 3.4 Global Non opioid Pain Patch Average Price by Manufacturers (2018-2023); 3.5 Manufacturers Non opioid Pain Patch Sales Sites, Area Served, Product Type; 3.6 Non opioid Pain Patch Market Competitive Situation and Trends; 3.6.1 Non opioid Pain Patch Market Concentration Rate; 3.6.2 Global 5 and 10 Largest Non opioid Pain Patch Players Market Share by Revenue; 3.6.3 Mergers & Acquisitions, Expansion
4 Non opioid Pain Patch Industry Chain Analysis: 4.1 Non opioid Pain Patch Industry Chain Analysis; 4.2 Market Overview of Key Raw Materials; 4.3 Midstream Market Analysis; 4.4 Downstream Customer Analysis
5 The Development and Dynamics of Non opioid Pain Patch Market: 5.1 Key Development Trends; 5.2 Driving Factors; 5.3 Market Challenges; 5.4 Market Restraints; 5.5 Industry News; 5.5.1 New Product Developments; 5.5.2 Mergers & Acquisitions; 5.5.3 Expansions; 5.5.4 Collaboration/Supply Contracts; 5.6 Industry Policies
6 Non opioid Pain Patch Market Segmentation by Type: 6.1 Evaluation Matrix of Segment Market Development Potential (Type); 6.2 Global Non opioid Pain Patch Sales Market Share by Type (2018-2023); 6.3 Global Non opioid Pain Patch Market Size Market Share by Type (2018-2023); 6.4 Global Non opioid Pain Patch Price by Type (2018-2023)
7 Non opioid Pain Patch Market Segmentation by Application: 7.1 Evaluation Matrix of Segment Market Development Potential (Application); 7.2 Global Non opioid Pain Patch Market Sales by Application (2018-2023); 7.3 Global Non opioid Pain Patch Market Size (M USD) by Application (2018-2023); 7.4 Global Non opioid Pain Patch Sales Growth Rate by Application (2018-2023)
8 Non opioid Pain Patch Market Segmentation by Region: 8.1 Global Non opioid Pain Patch Sales by Region; 8.1.1 Global Non opioid Pain Patch Sales by Region; 8.1.2 Global Non opioid Pain Patch Sales Market Share by Region; 8.2 North America; 8.2.1 North America Non opioid Pain Patch Sales by Country; 8.2.2 U.S.; 8.2.3 Canada; 8.2.4 Mexico; 8.3 Europe; 8.3.1 Europe Non opioid Pain Patch Sales by Country; 8.3.2 Germany; 8.3.3 France; 8.3.4 U.K.; 8.3.5 Italy; 8.3.6 Russia; 8.4 Asia Pacific; 8.4.1 Asia Pacific Non opioid Pain Patch Sales by Region; 8.4.2 China; 8.4.3 Japan; 8.4.4 South Korea; 8.4.5 India; 8.4.6 Southeast Asia; 8.5 South America; 8.5.1 South America Non opioid Pain Patch Sales by Country; 8.5.2 Brazil; 8.5.3 Argentina; 8.5.4 Columbia; 8.6 Middle East and Africa; 8.6.1 Middle East and Africa Non opioid Pain Patch Sales by Region; 8.6.2 Saudi Arabia; 8.6.3 UAE; 8.6.4 Egypt; 8.6.5 Nigeria; 8.6.6 South Africa
9 Key Companies Profile: 9.1 Hisamitsu; 9.1.1 Hisamitsu Non opioid Pain Patch Basic Information; 9.1.2 Hisamitsu Non opioid Pain Patch Product Overview; 9.1.3 Hisamitsu Non opioid Pain Patch Product Market Performance; 9.1.4 Hisamitsu Business Overview; 9.1.5 Hisamitsu Non opioid Pain Patch SWOT Analysis; 9.1.6 Hisamitsu Recent Developments; 9.2 Mylan; 9.2.1 Mylan Non opioid Pain Patch Basic Information; 9.2.2 Mylan Non opioid Pain Patch Product Overview; 9.2.3 Mylan Non opioid Pain Patch Product Market Performance; 9.2.4 Mylan Business Overview; 9.2.5 Mylan Non opioid Pain Patch SWOT Analysis; 9.2.6 Mylan Recent Developments; 9.3 Johnson andamp; Johnson; 9.3.1 Johnson andamp; Johnson Non opioid Pain Patch Basic Information; 9.3.2 Johnson andamp; Johnson Non opioid Pain Patch Product Overview; 9.3.3 Johnson andamp; Johnson Non opioid Pain Patch Product Market Performance; 9.3.4 Johnson andamp; Johnson Business Overview; 9.3.5 Johnson andamp; Johnson Non opioid Pain Patch SWOT Analysis; 9.3.6 Johnson andamp; Johnson Recent Developments; 9.4 Actavis; 9.4.1 Actavis Non opioid Pain Patch Basic Information; 9.4.2 Actavis Non opioid Pain Patch Product Overview; 9.4.3 Actavis Non opioid Pain Patch Product Market Performance; 9.4.4 Actavis Business Overview; 9.4.5 Actavis Non opioid Pain Patch SWOT Analysis; 9.4.6 Actavis Recent Developments; 9.5 Lingrui; 9.5.1 Lingrui Non opioid Pain Patch Basic Information; 9.5.2 Lingrui Non opioid Pain Patch Product Overview; 9.5.3 Lingrui Non opioid Pain Patch Product Market Performance; 9.5.4 Lingrui Business Overview; 9.5.5 Lingrui Non opioid Pain Patch SWOT Analysis; 9.5.6 Lingrui Recent Developments; 9.6 Teikoku Seiyaku; 9.6.1 Teikoku Seiyaku Non opioid Pain Patch Basic Information; 9.6.2 Teikoku Seiyaku Non opioid Pain Patch Product Overview; 9.6.3 Teikoku Seiyaku Non opioid Pain Patch Product Market Performance; 9.6.4 Teikoku Seiyaku Business Overview; 9.6.5 Teikoku Seiyaku Recent Developments; 9.7 Sanofi; 9.7.1 Sanofi Non opioid Pain Patch Basic Information; 9.7.2 Sanofi Non opioid Pain Patch Product Overview; 9.7.3 Sanofi Non opioid Pain Patch Product Market Performance; 9.7.4 Sanofi Business Overview; 9.7.5 Sanofi Recent Developments; 9.8 Novartis; 9.8.1 Novartis Non opioid Pain Patch Basic Information; 9.8.2 Novartis Non opioid Pain Patch Product Overview; 9.8.3 Novartis Non opioid Pain Patch Product Market Performance; 9.8.4 Novartis Business Overview; 9.8.5 Novartis Recent Developments; 9.9 Qizheng; 9.9.1 Qizheng Non opioid Pain Patch Basic Information; 9.9.2 Qizheng Non opioid Pain Patch Product Overview; 9.9.3 Qizheng Non opioid Pain Patch Product Market Performance; 9.9.4 Qizheng Business Overview; 9.9.5 Qizheng Recent Developments; 9.10 Endo; 9.10.1 Endo Non opioid Pain Patch Basic Information; 9.10.2 Endo Non opioid Pain Patch Product Overview; 9.10.3 Endo Non opioid Pain Patch Product Market Performance; 9.10.4 Endo Business Overview; 9.10.5 Endo Recent Developments; 9.11 Huarun 999; 9.11.1 Huarun 999 Non opioid Pain Patch Basic Information; 9.11.2 Huarun 999 Non opioid Pain Patch Product Overview; 9.11.3 Huarun 999 Non opioid Pain Patch Product Market Performance; 9.11.4 Huarun 999 Business Overview; 9.11.5 Huarun 999 Recent Developments; 9.12 GSK; 9.12.1 GSK Non opioid Pain Patch Basic Information; 9.12.2 GSK Non opioid Pain Patch Product Overview; 9.12.3 GSK Non opioid Pain Patch Product Market Performance; 9.12.4 GSK Business Overview; 9.12.5 GSK Recent Developments; 9.13 Haw Par; 9.13.1 Haw Par Non opioid Pain Patch Basic Information; 9.13.2 Haw Par Non opioid Pain Patch Product Overview; 9.13.3 Haw Par Non opioid Pain Patch Product Market Performance; 9.13.4 Haw Par Business Overview; 9.13.5 Haw Par Recent Developments; 9.14 Nichiban; 9.14.1 Nichiban Non opioid Pain Patch Basic Information; 9.14.2 Nichiban Non opioid Pain Patch Product Overview; 9.14.3 Nichiban Non opioid Pain Patch Product Market Performance; 9.14.4 Nichiban Business Overview; 9.14.5 Nichiban Recent Developments; 9.15 Mentholatum; 9.15.1 Mentholatum Non opioid Pain Patch Basic Information; 9.15.2 Mentholatum Non opioid Pain Patch Product Overview; 9.15.3 Mentholatum Non opioid Pain Patch Product Market Performance; 9.15.4 Mentholatum Business Overview; 9.15.5 Mentholatum Recent Developments; 9.16 Laboratoires Genevrier; 9.16.1 Laboratoires Genevrier Non opioid Pain Patch Basic Information; 9.16.2 Laboratoires Genevrier Non opioid Pain Patch Product Overview; 9.16.3 Laboratoires Genevrier Non opioid Pain Patch Product Market Performance; 9.16.4 Laboratoires Genevrier Business Overview; 9.16.5 Laboratoires Genevrier Recent Developments; 9.17 BLUE-EMU; 9.17.1 BLUE-EMU Non opioid Pain Patch Basic Information; 9.17.2 BLUE-EMU Non opioid Pain Patch Product Overview; 9.17.3 BLUE-EMU Non opioid Pain Patch Product Market Performance; 9.17.4 BLUE-EMU Business Overview; 9.17.5 BLUE-EMU Recent Developments
10 Non opioid Pain Patch Market Forecast by Region: 10.1 Global Non opioid Pain Patch Market Size Forecast; 10.2 Global Non opioid Pain Patch Market Forecast by Region; 10.2.1 North America Market Size Forecast by Country; 10.2.2 Europe Non opioid Pain Patch Market Size Forecast by Country; 10.2.3 Asia Pacific Non opioid Pain Patch Market Size Forecast by Region; 10.2.4 South America Non opioid Pain Patch Market Size Forecast by Country; 10.2.5 Middle East and Africa Forecasted Consumption of Non opioid Pain Patch by Country
11 Forecast Market by Type and by Application (2024-2029): 11.1 Global Non opioid Pain Patch Market Forecast by Type (2024-2029); 11.1.1 Global Forecasted Sales of Non opioid Pain Patch by Type (2024-2029); 11.1.2 Global Non opioid Pain Patch Market Size Forecast by Type (2024-2029); 11.1.3 Global Forecasted Price of Non opioid Pain Patch by Type (2024-2029); 11.2 Global Non opioid Pain Patch Market Forecast by Application (2024-2029); 11.2.1 Global Non opioid Pain Patch Sales (K MT) Forecast by Application; 11.2.2 Global Non opioid Pain Patch Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings